SCHEMBL56356

SCHEMBL56356

CCC([C]=O)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6738125 0.96
SCHEMBL269384 0.81
SCHEMBL3862023 0.81
SCHEMBL4966155 0.81
SCHEMBL9021622 0.81
SCHEMBL18339440 0.78
SCHEMBL22572819 0.76
SCHEMBL15759 0.76
SCHEMBL3812944 0.76
SCHEMBL4971091 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2271 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448924-B Use of nucleoside analogues or combination formulations containing nucleoside analogues in antiviral therapy 中国科学院上海药物研究所 2024-06-18 CN claimed
CN-118159542-A Substituted 2, 3-dihydro [1,3] thiazolo [4,5-b ] pyridines, salts thereof and their use as herbicidal agents 拜耳公司 2024-06-07 CN claimed
US-11919923-B2 Antiviral application of nucleoside analog or combination formulation containing nucleoside analog SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2024-03-05 US claimed
CN-117586262-A Nucleoside analogues and uses thereof 苏州旺山旺水生物医药有限公司 2024-02-23 CN claimed
WO-2024027844-A1 PHARMACEUTICAL COMPOSITION AND USE THEREOF 临港国家实验室 2024-02-08 WO claimed
CN-117503776-A Pharmaceutical composition and application thereof 临港国家实验室 2024-02-06 CN claimed
WO-2024002112-A1 METHOD FOR TREATING FELINE CORONAVIRUS OR CALICIVIRUS INFECTION 苏州旺山旺水生物医药股份有限公司 2024-01-04 WO claimed
CN-117298120-A A method for treating cat coronal or calicivirus infection 苏州旺山旺水生物医药股份有限公司 2023-12-29 CN claimed
EP-3666754-B1 FULLY CONTINUOUS FLOW PRODUCTION PROCESS FOR DIRECTLY PREPARING ORGANIC PEROXIDE FROM ALCOHOL OR ALKANE SHANGHAI HYBRID CHEM TECH (CN) 2023-03-29 EP claimed
US-11596716-B2 Compounds and matrices for use in bone growth and repair HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2023-03-07 US claimed
EP-0690055-A1 Stereoselective process for making endo-tropanamine and like compounds ELI LILLY AND COMPANY (US) 1996-01-03 EP claimed
EP-0411332-B1 Antiviral peptides having a 2-oxoalkyl amino acid side chain BIO MEGA BOEHRINGER INGELHEIM (CA) 1995-12-06 EP claimed
EP-0514359-B1 Alkanoyl L-carnitine amides with aminoacids and pharmaceutical compositions containing same, for promoting regeneration of the nervous tissue, inhibiting neuronal degeneration, enhancing the processes of learning and memory, and for the treatment of coma SIGMA TAU IND FARMACEUTI (IT) 1995-09-13 EP claimed
EP-0411333-B1 Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain BIO MEGA BOEHRINGER INGELHEIM (CA) 1995-05-31 EP claimed
US-5270472-A Alkanoyl L-carnitine amides with aminoacids and pharmaceutical compositions containing same for promoting regeneration of the nervous tissue, inhibiting neuronal degeneration, enhancing the process of learning and memory and for the treatment of coma SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1993-12-14 US claimed
EP-0514359-A2 Alkanoyl L-carnitine amides with aminoacids and pharmaceutical compositions containing same, for promoting regeneration of the nervous tissue, inhibiting neuronal degeneration, enhancing the processes of learning and memory, and for the treatment of coma Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1992-11-19 EP claimed
EP-0443573-A2 HIV protease inhibitors containing derived amino acids BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1991-08-28 EP claimed
EP-0443560-A2 HIV protease inhibitors BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1991-08-28 EP claimed
EP-0411333-A1 Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1991-02-06 EP claimed
EP-0411332-A1 Antiviral peptides having a 2-oxoalkyl amino acid side chain BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1991-02-06 EP claimed